microdose glp 1 perimenopause Microdosing GLP-1 in & Menopause ✨ Let's talk about microdosing GLP-1 during perimenopause & menopause ✨ If you've ever said: • “I'm eating the same but gaining weight” • “My cravings HRT + GLP-1 for Perimenopause

Start With a Provider-Led GLP-1 Plan If you want telehealth care that feels personal, Start Your GLP-1 Program Today with Independent Wellness

Furthermore, the cardiovascular benefits emerged early in treatment, preceding significant weight loss, suggesting that the cardiovascular effects may be mediated, at least partially, by other salutary processes in atherosclerotic protection

adults do not meet recommended fruit and vegetable intake guidelines (1.52 cups of fruit and 23 cups of vegetables daily)

This stimulation increases your heart rate and blood pressure while simultaneously decreasing your appetite

Six weeks is typically the time doctors begin offering laser therapy for scars

Introduction Concerns about thyroid cancer with glucagon-like peptide 1 (GLP1) receptor agonist use were first raised in the premarketing phase after studies showed increased rates of thyroid C cell tumours in rodents.1 While the relevance of these findings to humans is not known, in the United States, product labels of GLP1 receptor agonists include boxed warnings about thyroid cancer and these drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2